Filing metadata

Accession number
0001209191-22-039256
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Jun 24, 2022
Reporting period
Jun 22, 2022
Description
Insider transaction

Explore SEC Filings Hub